Progyny, Inc. (NASDAQ:PGNY) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Progyny, Inc. (NASDAQ:PGNY) have earned a consensus recommendation of “Hold” from the thirteen analysts that are currently covering the firm, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $23.64.

A number of brokerages have recently commented on PGNY. JPMorgan Chase & Co. increased their price objective on Progyny from $17.00 to $23.00 and gave the company a “neutral” rating in a report on Tuesday, January 28th. Bank of America increased their price target on Progyny from $21.00 to $25.00 and gave the company a “buy” rating in a report on Tuesday, February 11th. Canaccord Genuity Group boosted their price objective on shares of Progyny from $17.00 to $23.00 and gave the stock a “hold” rating in a research note on Friday, February 28th. Finally, BTIG Research upgraded shares of Progyny from a “neutral” rating to a “buy” rating and set a $28.00 target price on the stock in a research note on Monday, March 31st.

Progyny Price Performance

Progyny stock opened at $22.34 on Monday. Progyny has a one year low of $13.39 and a one year high of $34.40. The company’s fifty day moving average price is $22.01 and its two-hundred day moving average price is $18.70. The company has a market capitalization of $1.91 billion, a price-to-earnings ratio of 38.52, a PEG ratio of 2.39 and a beta of 1.33.

Institutional Investors Weigh In On Progyny

A number of institutional investors have recently added to or reduced their stakes in the company. Signaturefd LLC raised its holdings in Progyny by 1,355.0% in the 4th quarter. Signaturefd LLC now owns 1,455 shares of the company’s stock valued at $25,000 after acquiring an additional 1,355 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Progyny by 341.4% during the fourth quarter. GAMMA Investing LLC now owns 1,611 shares of the company’s stock valued at $28,000 after purchasing an additional 1,246 shares during the period. Nisa Investment Advisors LLC raised its stake in shares of Progyny by 108.4% in the fourth quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company’s stock valued at $51,000 after purchasing an additional 1,526 shares in the last quarter. Caitlin John LLC lifted its position in Progyny by 2,974.8% in the fourth quarter. Caitlin John LLC now owns 3,290 shares of the company’s stock worth $57,000 after purchasing an additional 3,183 shares during the period. Finally, Natixis acquired a new stake in Progyny during the fourth quarter worth $69,000. 94.93% of the stock is owned by institutional investors and hedge funds.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.